PHOTOTHERA LASER SYSTEM FEASIBILITY ASSESSMENT

PHOTOTHERA INC.,0 个研究点目标入组 0 人开始时间: 2004年4月21日最近更新: 2023年9月4日

试验速览

暂无简介。

•The Subject is at least 40 years old at the time of detection, but has not reached his 85th birthday.
•The Subject suffers from acute ischemic stroke.
•Possibility of starting treatment with photothera laser system within 24 hours of the start of the ACV
•The subject and / or his / her legal representative give their informed consent before taking the study.
•The Subject wishes to participate in this study for at least 3 months after the start of the ACV.

•The Subject has been presented to the Community hospital more than 24 hours after the start of the ACV.
•Evidence of intracranial, subdural or subarachnoid hemorrhage in the CT scan
•The subject is a candidate for intravenous administration of tissue plasminogen activator (tPA) for the treatment of acute ischemic stroke and is administered tPA.
•The Subject had convulsions at the beginning of the ACV.
•Serum glucose greater than 400 mg / dL or less than 40 mg / dL.

发起方